Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02231398 · ClinicalTrials.gov registry record
nuMoM2b Heart Health Study
A clinical trial, sponsored by RTI International.
- Completed
- Registry status
- 4,509
- Enrollment target
NCT02231398: Completed study, sponsored by RTI International.
NCT02231398 is a clinical trial that has completed, run by RTI International. The registered enrollment target is 4,509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02231398 has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- 4,509 participants
- Enrollment target
Study Summary
This study is looking at the relationship between experiences during pregnancy and cardiovascular health 2 to 3½ years later. The investigators are recruiting women from the approximately 10,000 women who were enrolled and followed over the course of their first pregnancy in another study.
Primary Outcome
Will exclude participants with chronic hypertension or pregestational diabetes during or just prior to the index pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,509 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-10-30 |
What the finished NCT02231398 record still lists
NCT02231398 is an observational study that tracks outcomes without assigning an intervention. Its 4,509 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02231398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02231398 about?
NCT02231398 is a clinical study titled "nuMoM2b Heart Health Study". This study is looking at the relationship between experiences during pregnancy and cardiovascular health 2 to 3½ years later. The investigators are recruiting women from the approximately 10,000 women who were enrolled and followed over the course of their first pregnancy in another study.
What is the current status of trial NCT02231398?
This trial is currently completed. The enrollment target is 4,509 participants. The study started on 2014-09. Estimated completion is 2020-10-30.
Who is sponsoring clinical trial NCT02231398?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702878 · 4,514 participants · Phase 3
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia